ウェビナー動画：Bristol Myers Squibb社、細胞株開発のためのNGSデータ解析の民主化
BMS社では、インハウスのNGSアッセイとSelectorを統合し、ワークフローの自動化や研究者への分野横断的なサポートを通じて、細胞株開発およびプロセス開発を変革しています。Playbookを活用することで、複雑なバイオインフォマティクスを直感的かつ自動化されたソリューションで民主化しています。
In this webinar, discover how Bristol Myers Squibb (BMS) is transforming their Cell Line and Process Development by combining in-house NGS assays with Genedata Selector to automate data workflows, reduce turnaround times, and empower scientists across disciplines.
Chaojie Wang, Senior Scientist at BMS, will share how the Genedata Selector Sequence Variant Analysis Playbook enables automation, reproducibility, and scalability in sequence variant (SV) detection. Through the collection of Playbooks — intuitive, user-friendly guides — Genedata Selector democratizes and automates complex bioinformatic workflows throughout Cell Line and Process Development while supporting regulatory compliance and cost-effective scalability.
Learn how BMS uses Genedata to:
- Automate SV detection workflows to accelerate Cell Line and Process Development.
- Empower scientists across disciplines with intuitive tools that eliminate bioinformatics bottlenecks.
- Ensure reproducibility and accuracy for Cell Line and Process Development NGS-based assays across teams and sites.
- Centralize and manage NGS data securely while maintaining full traceability.
- Enable insights by structuring genomics data within a scalable IT infrastructure.
- Reduce turnaround times and costs by bringing NGS and analysis in-house.
Who Should Watch:
- R&D Scientists & Process Engineers: Learn how to streamline SV analysis and improve the quality of NGS data generated throughout Cell Line Development.
- Bioinformaticians & Data Scientists: Discover how Playbooks simplify complex analytics and how automation accelerates bioinformatics workflows across teams.
- IT & Digital Transformation Leaders: See how scalable platforms support secure, compliant NGS workflows and AI-readiness.
- Quality & Regulatory Professionals: Find out how Genedata Selector's GMP-compliant features support audit readiness and data traceability.
- Biopharma Executives: Gain insights into how digitalization high ROI, faster turnaround, and innovation in development.